Congress approves $100 million in prostate cancer research funding through DoD

When it passed the Omnibus appropriations bill for the financial year 2018 at the end of last week, Congress increased funding for prostate cancer research from $80 to $100 million through the Department of Defense’s Congressionally Directed Medical Research Program (CDRMP). … READ MORE …

A piece of good news from Washington, DC

The “New” Prostate Cancer InfoLink has heard that, as part of the final resolution of the US federal budget for fiscal year 2017 (which passed the Senate yesterday), there has been a $10 million increase in funding for the Prostate Cancer Research Program (PCRP) within the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP). … READ MORE …

Funding for DoD CDMRP prostate cancer research in 2014

According to the Report of the U.S. House of Representatives’ Committee on Appropriations (see p. 273) it is currently proposed that the Prostate Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Program will again receive $80 million in funding for the financial year 2014. … READ MORE …

It’s time to badger your Congressman/Congresswoman again …

As the annual Defense appropriations cycle starts once again, The “New” Prostate Cancer InfoLink encourages all you US-based prostate cancer patients and other US-based voters to e-mail your Congressman or Congresswoman and ask them to support prostate cancer research funding through the “Dear Colleague” letter being circulated by Representative Pete King in the House. … READ MORE …

DoD CDMRP funding and prostate cancer research for FY 2012

It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense’s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important “win” for prostate cancer research during a time of fiscal constraint. … READ MORE …

It’s time to badger Congress — yet again, pretty please!

Many readers will already have seen the report we posted about Senator McCain’s desire to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) — one of the most successful prostate cancer research initiatives. Now you can work with the rest of the advocacy community to counter this. … READ MORE …

48 hours at the IMPaCT symposium in Orlando: Part III

So the question any smart prostate cancer patient should ask himself — especially if he has any degree of good scientific education — is, “How do I get myself invited to the next IMPaCT meeting?” … READ MORE …